Skip to Content

Medications for Peripheral Neuropathy

Drugs associated with Peripheral Neuropathy

The following drugs and medications are in some way related to, or used in the treatment of this condition.

What is Peripheral Neuropathy: Peripheral neuropathy is failure of the nerves that carry information to and from the brain and spinal cord. This produces symptoms like pain, loss of sensation, and inability to control muscles.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
gabapentin Off Label Rx C N X 105 reviews
7.0

Generic name: gabapentin systemic

Drug class: gamma-aminobutyric acid analogs

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
L-Carnitine Off Label Rx B N Add review Add

Generic name: levocarnitine systemic

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

Off Label: Yes

 
carbamazepine Off Label Rx D N X 7 reviews
7.0

Generic name: carbamazepine systemic

Drug class: dibenzazepine anticonvulsants

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
levocarnitine Off Label Rx B N Add review
4.0

Generic name: levocarnitine systemic

Brand names:  L-Carnitine, Carnitor, Carnitor SF

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Qutenza Off Label Rx B N 1 review Add

Generic name: capsaicin topical

Drug class: miscellaneous topical agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

 
capsaicin Off Label Rx/OTC B N 4 reviews
9.0

Generic name: capsaicin topical

Brand name:  Qutenza

Drug class: miscellaneous topical agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

Off Label: Yes

 
duloxetine Off Label Rx C N X 18 reviews
6.0

Generic name: duloxetine systemic

Drug class: serotonin-norepinephrine reuptake inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Carnitor Off Label Rx B N Add review Add

Generic name: levocarnitine systemic

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Carnitor SF Off Label Rx B N Add review
4.0

Generic name: levocarnitine systemic

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

 
pregabalin Off Label Rx C 5 X 20 reviews
7.0

Generic name: pregabalin systemic

Drug class: gamma-aminobutyric acid analogs

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Off Label: Yes

 
phenytoin Off Label Rx D N X 2 reviews
1.0

Generic name: phenytoin systemic

Drug class: hydantoin anticonvulsants, group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Showing all

Topics under Peripheral Neuropathy

Alternative treatments for Peripheral Neuropathy

The following products are considered to be alternative treatments or natural remedies for Peripheral Neuropathy. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However there may be historical, cultural or anecdotal evidence linking their use to the treatment of Peripheral Neuropathy.

Learn more about Peripheral Neuropathy

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N The drug is not subject to the Controlled Substances Act.
1 The drug has a high potential for abuse. The drug has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug under medical supervision.
2 The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
3 The drug has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
4 The drug has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
5 The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
Alcohol
X Interacts with Alcohol.

Synonym(s): Neuropathy

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide